Skip to main content
Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Impact of excessive gestational weight gain on exclusive breastfeeding among women with Type 1 and Type 2 diabetes and obesity

  • Leandro Cordero ,

    Roles Conceptualization, Data curation, Formal analysis, Funding acquisition, Investigation, Methodology, Project administration, Supervision, Validation, Visualization, Writing – original draft, Writing – review & editing

    leandro.cordero@osumc.edu

    Affiliation Department of Pediatrics, College of Medicine, The Ohio State University Wexner Medical Center, Columbus, OH, United States of America

  • Michael R. Stenger,

    Roles Conceptualization, Formal analysis, Methodology, Visualization, Writing – review & editing

    Affiliation Department of Pediatrics, College of Medicine, The Ohio State University Wexner Medical Center, Columbus, OH, United States of America

  • Mark B. Landon,

    Roles Writing – review & editing

    Affiliation Department of Obstetrics and Gynecology, College of Medicine, The Ohio State University Wexner Medical Center, Columbus, OH, United States of America

  • Craig A. Nankervis

    Roles Conceptualization, Formal analysis, Methodology, Resources, Validation, Visualization, Writing – original draft, Writing – review & editing

    Affiliation Department of Pediatrics, College of Medicine, The Ohio State University Wexner Medical Center, Columbus, OH, United States of America

Abstract

Background

Pregestational diabetes, obesity and gestational weight gain (GWG) are associated with adverse perinatal outcomes, however, the influence of excessive GWG on lactation at discharge is less known. Our aim is to evaluate the impact of excessive GWG using the LifeCycle project guidelines on exclusive breastfeeding (EBF) and any BF rates at discharge among 171 women with Type 1 and 294 Type 2 diabetes and obesity who intended to BF.

Methods and findings

Retrospective cohort study. Obesity was defined by BMI (kg/m2) as grade 1 (30–34.9), grade 2 (35–39.9) or grade 3 (≥40). GWG was categorized as adequate, inadequate or excessive according to the 2019 LifeCycle Project guidelines. Women with Type 1 were younger (30 vs 33y), primiparous (51 vs 32%), delivered earlier (37 vs 38w) than women with Type 2 andwere different in grade 1 (40 vs 26%), grade 3 obesity (19 vs 49%) and median GWG (15 vs 11kg). Of all 465 women with Type 1 and Type 2 combined, 365 (78%) who had excessive GWG and 100 (22%) who had non-excessive GWG showed similar EBF (27 vs 25%) and any BF (72 vs 72%) rates. Regression analysis showed that after adjusting for potential confounders excessive GWG was not a predictor of EBF or any BF at discharge.

Conclusion

Type 1 and Type 2 diabetes, obesity and excessive GWG are associated with low EBF, however, excessive GWG is not an independent predictor of low EBF or any BF at discharge.

1. Background

Lactation provides short- and long-term health benefits to mothers and infants following healthy as well as high risk pregnancies [14]. More specifically, exclusive breastfeeding (EBF) during birth hospitalization and the first postpartum year have been designated desirable goals [5,6]. Comorbidities such as gestational or pregestational diabetes mellitus and maternal obesity have been independently recognized as significant obstacles to BF initiation and duration [711].

Among healthy women gestational weight gain (GWG) has received attention from investigators and clinicians because it is a potentially modifiable factor which may impact pregnancy outcomes [12,13]. The Institute of Medicine (IOM) 2009 guidelines recommended GWG to be 5-9kg (10–20 lbs) for all women with BMI ≥ 30kg/m2 [12,13]. Since then, several investigations have focused on the impact of adequate, inadequate or excessive GWG on maternal and neonatal outcomes [12,13]. GWG above the IOM target range has been associated with an increased risk of gestational diabetes, pregnancy-related hypertension, macrosomia, large for gestational age infants and cesarean delivery [12,13]. To date, few publications have addressed the impact of excessive GWG on EBF or BF duration [1417].

One limitation of the 2009 guidelines was the failure to provide specific GWG recommendations for women among different obesity classes as well as for women with diabetes [13]. In 2019, the LifeCycle project proposed specific GWG guidelines for women with grade 1 obesity (BMI 30–34.9kg/m2), grade 2 (BMI 35–39.9kg/m2) and grade 3 (BMI ≥ 40kg/m2) [18]. However, studies of associations of excessive GWG with EBF and BF initiation using the new guidelines are not available.

1.1 Objective

Our aim was to evaluate the impact of excessive GWG using the LifeCycle project guidelines on EBF and any BF rates at discharge among 171 women with Type 1 and 294 women with Type 2 diabetes and obesity who intended to BF.

2. Methods and findings

The Ohio State University Biomedical Science IRB approved on 5/02/2022 the continuation of the study #2010H0198 with waivers of informed consent and HIPAA research authorization. All methods were performed in accordance with the relevant guidelines and regulations of the declaration of Helsinki. Electronic maternal and neonatal records (2013–20) were reviewed. Some information obtained from women who delivered between 2013 and 2018 was used in previous investigations [79]. Type 1 and Type 2 pregestational diabetes, chronic hypertension (CHTN) and preeclampsia were diagnosed and treated in accordance with established guidelines [1921]. GWG was calculated using weight at delivery minus pregestational weight measured during the first trimester or recalled at the time of delivery [12]. In the present study, women were categorized by prepregnancy BMI as normal (18.5–24.9 kg/m), overweight (25–29.9 kg/m2), obese grade 1 (30–34.9 kg/m2), obese grade 2 (35–39.9 kg/m2) or obese grade 3 (≥ 40 kg/m2) [18]. According to LifeCycle guidelines, GWG was categorized as adequate (within guidelines), inadequate (below) or excessive (above) [13,18].

All women delivered singleton infants at ≥ 34 weeks gestation; pregnancies affected by major fetal malformations were not included in the study. Health insurance type was used as a proxy for socioeconomic status [22]. Upon arrival to labor and delivery, each woman described her past BF experience and her intention to exclusively or partially BF. In our institution, maternity practices include BF within 1 hour of delivery, no formula supplementation unless indicated, rooming in, on demand BF, full-time lactation consultants and post discharge BF support [8,9]. Furthermore, our institution reports BF data to the Joint Commission as required for hospital accreditation [5].

Per our hospital practice, any symptomatic infants were directly transferred from the delivery room to the NICU for further care. Following delivery, if the condition of the mother and her infant allowed, maternal-infant interactions such as holding, skin-to-skin contact, and BF were encouraged. Asymptomatic infants able to feed were transferred to the Newborn Nursery for routine care and glucose monitoring [79]. According to standard intrauterine growth charts, all infants were categorized as appropriate for gestational age (AGA), small for gestational age (SGA), large for gestational age (LGA) or macrosomic (birthweight ≥ 4000g) [23].

Screening for hypoglycemia (blood glucose < 40 mg/dl) was done via serial point of care testing (Accu-Chek®) or by plasma glucose measurement in the laboratory (Beckman Coulter AU5800, Beckman Coulter Inc., Brea, CA, U.S.A.) starting within the first hour of life after the first feeding and every 2–4 hours thereafter as needed. Asymptomatic infants in the Newborn Nursery with hypoglycemia were promptly BF, formula fed (FF) or given dextrose gel and those with recurrent hypoglycemia were transferred to the NICU for further care. On admission to the NICU, most infants were started on intravenous (IV) dextrose and those who were able to feed were BF or FF [8].

BF was considered early if given within the first two postpartum hours. EBF was defined as direct feedings from the breast or expressed breast milk (EBM) alone or in combination with direct BF. Partial BF was defined as formula supplementation with direct BF or with EBM. BF was considered initiated if, during the 24 hours preceding hospital discharge, infants were EBF or BF partially [79]. Due to the retrospective study design, no follow-up information was available on infant feeding practices following hospital discharge.

3. Statistical analysis

Comparisons between women with Type 1 and Type 2 pregestational diabetes were made with Mood’s median tests for continuous variables and Chi square tests for categorical variables. Significance was established at a p value < 0.05. Univariate and multivariate logistic regression were used to ascertain the strength of association of Type 1 and Type 2 diabetes, obesity and GWG with EBF and BF initiation at discharge controlling for maternal variables (CHTN, preeclampsia, mothers age, race, health insurance type, smoking during pregnancy, BMI, parity, mode of delivery, prior BF, BF within two hours from birth) and neonatal variables (prematurity, AGA, SGA, LGA, admission to NICU, neonatal hypoglycemia and infant length of stay).

4. Results

4.1 Maternal and neonatal outcomes for women with diabetes and obesity

Clinical and demographic characteristics of 171 women with Type 1 and 294 women with Type 2 diabetes and obesity are shown in Table 1. Median pregestational BMI was lower for women with Type 1 (35 kg/m2) than for Type 2 (39 kg/m2). Among those with Type 1, obesity grade 1 (40 vs 26%) was higher while that of grade 3 was lower (29 vs 49%) than among women with Type 2 diabetes. Prevalence of obesity grade 2 (31 vs 25%), rates of CHTN alone (18 vs 32%) and preeclampsia superimposed on CHTN (7 vs 8%) were comparable for women with Type 1 and Type 2. Preeclampsia as a single co-morbidity was more common among Type 1 than Type 2 (20 vs 5%). Preeclampsia alone or superimposed on CHTN combined affected 47 (27%) women of Type 1 and 39 (13%) of Type 2 (p ≤ 0.001). All women with preeclampsia with severe features received 24 hours of magnesium sulfate seizure prophylaxis.

thumbnail
Table 1. Maternal and Neonatal outcomes for women with diabetes and obesity.

https://doi.org/10.1371/journal.pone.0277599.t001

Women with Type 1 diabetes were more likely to be primiparous (50 vs 32%), younger (median age 30 vs 33), white (69 vs 39%) and less often Hispanic (5 vs 26%) than those in the Type 2 group. Smoking during pregnancy occurred with similar frequency among women with Type 1 and Type 2 diabetes (6 vs 7%). Public assistance was more common among women with Type 2 diabetes (62 vs 40%). Cesarean deliveries occurred with similar frequency (66 vs 62%) in both groups, while maternal length of hospital stay was slightly longer among Type 1 diabetics.

Infants born to women with Type 1 were of lower median gestational age (37 vs 38w) and higher median birthweight (3614 vs 3478g) than those of Type 2. Both groups were comparable in incidence of SGA (2 vs 3%), LGA (43 vs 39%)and AGA infants (55 vs 58%).

Neonatal hypoglycemia (59 vs 42%) and admission to the NICU (45 vs 23%) was more common among infants born to women in the Type 1 group. Considering the similarities in diagnoses, 77 infants from the Type 1 group and 69 infants from the Type 2 group admitted to the NICU were combined for analysis. Eighty-three of the 146 (57%) infants were admitted to the NICU directly from the delivery room while the remaining 63 (43%) stayed in the newborn nursery for a short time prior to transfer. Primary admission diagnoses to the NICU included hypoglycemia (50%), respiratory distress (27%), apnea-bradycardia-cyanosis (10%), temperature instability-hypotonia-poor feeding (10%) and miscellaneous (3%). EBF and BF initiation at discharge were similar for Type 1 and Type 2 groups (30 vs 24%) and (75 vs 69%), respectively. A comparison of BF outcomes for 146 infants admitted to the NICU and 319 others admitted to the Newborn Nursery showed that exclusive BF (27 vs 26%) and BF initiation (72 vs 71%) were not different. On the other hand, BF outcomes for 223 infants with hypoglycemia and 242 others without hypoglycemia showed that exclusive BF rates were lower (20 vs 33%, p 0.003) while BF initiation (70 vs 73%) was no different between the two groups. All mothers and their infants were discharged home in good condition.

4.2 Study population according to infant feeding preference

Considering that our regression analysis showed that BF initiation (any BF) at discharge was more likely among women with Type 1 who intended to exclusively BF, we divided the entire population into 384 women who intended to exclusively BF and 81 who intended to partially BF (Table 2). Our data showed that intention to exclusively BF was more common among primiparous white women with Type 1 diabetes. Smoking during pregnancy occurred with similar frequency among women who intended exclusive BF and those who intended partial BF (5 vs 12%). Public assistance was more frequent among women who intended partial BF (77 vs 56%). At the time of discharge, EBF and BF initiation rates were higher among women who intended to BF exclusively compared to those who intended to BF partially (31 vs 6% and 77 vs 44%, respectively).

thumbnail
Table 2. Study population according to infant feeding preference.

https://doi.org/10.1371/journal.pone.0277599.t002

4.3 Maternal and neonatal outcomes according to GWG

In order to calculate GWG, pregestational weight was measured in 76% and recalled in 24% of women with Type 1 and measured in 69% and recalled in 31% of women with Type 2 diabetes. Combining the entire study population of women with Type 1 and Type 2, we determined that 17 (4%) had inadequate GWG, 83 (18%) had adequate GWG and 365 (78%) had excessive GWG. The 365 women with excessive GWG were compared to the 100 women with non-excessive GWG (Table 3). Those with excessive GWG were more likely to be Type 1, white, primiparous, delivered by primary cesarean and have lower pregestational weight. Smoking during pregnancy occurred with similar frequency among both groups of women (5 vs 12%). Public assistance was less common among women with excessive GWG (57 vs 69%). Birthweight and rate of LGA were higher among infants born to women with excessive GWG, however, the rates of hypoglycemia and the need for NICU care were similar to those in the non-excessive GWG group. At the time of discharge, the excessive and non-excessive GWG groups had similar EBF (27 vs 25%), partial BF (44 vs 47%) and any BF (72 vs 72%) rates. Two hundred and thirteen women of the 365 (58%) with excessive GWG were multiparous. One hundred and fifty-nine (75%) of them had prior BF experience. At the time of discharge, 30% of the multiparous with prior BF experience and 19% of the 67 without prior experience had EBF (p 0.007).

thumbnail
Table 3. Maternal and neonatal outcomes according to gestational weight gain.

https://doi.org/10.1371/journal.pone.0277599.t003

4.4 Maternal

Maternal obesity, GWG and infant feeding at discharge.

The study population was categorized according to obesity grades (Table 4). Thirty-one percent of women were classified as grade 1, 27% grade 2 and 42% were grade 3. Prevalence of adequate GWG increased from grade 1 to grade 3 (12–24% p < 0.005), while inadequate GWG was found only in Grade 1 (12%). The prevalence of excessive GWG among the three obesity groups was similar.

thumbnail
Table 4. Maternal obesity, gestational weight gain and infant feeding at discharge.

https://doi.org/10.1371/journal.pone.0277599.t004

At the time of discharge, the rate of EBF was higher among grades 1 and 2 (28 and 33%) than in grade 3 (22%) (p 0.03). Partial BF occurred with similar frequency across the three obesity groups (48, 40 and 46%, respectively). Consequently, BF initiation was comparable between grade 1 and grade 2 (76 vs 73%) but slightly lower among grade 3 (68%). Of all 465 study patients combined, there were 124 (27%) who EBF and of them 77 (62%) BF by direct BF while 47 (38%) received exclusive EBM. During the hospitalization, 12 infants from the EBF group received donor human milk.

4.5 Regression analysis and GWG associations

Our regression analysis showed that the stronger predictors for EBF at discharge were intention to BF exclusively for women with Type 1 DM (a OR 9.580, 95% CI, 1.163–78.900) and for women with Type 2 DM (a OR 6.571, 95% CI, 2.240–19.279). Conversely, the stronger predictors of failure for EBF were neonatal hypoglycemia for Type 1 DM (a OR 0.317, 95% CI, 0.154–0.651) and for Type 2 (a OR 0.419, 95% CI, 0.230–0.765).

The stronger predictors of BF initiation (any BF) at discharge for Type 1 DM were intention to BF exclusively (a OR 4.598, 95% CI, 1.419–14.904) and for Type 2 DM (a OR 5.050, 95% CI, 2.540–10.042). Conversely, the major obstacles for BF initiation (any BF) failure at discharge for Type 2 were preeclampsia (a OR 0.294, 95% CI, 0.126–0.684), public assistance (a OR 0.390, 95% CI, 0.195–0.782) and neonatal hypoglycemia (a OR 0.547, 95% CI, 0.305–0.982).

After controlling for potential confounders, none of the GWG categories (adequate, inadequate and excessive) were predictors of EBF or BF initiation at discharge.

5. Discussion

The American Academy of Pediatrics and the Academy of Breastfeeding Medicine recommend EBF for all healthy infants during birth hospitalization and beyond [6,24]. These organizations acknowledge that in the presence of maternal and neonatal morbidities, other nutritional options may be needed to temporarily replace or supplement BF [6,24]. Concurrently, since January 2014, the Joint Commission mandated the reporting of EBF rates during hospitalization for healthy infants to retain their maternity accreditation [5]. In a recent study of maternity care practices and policies in 1,305 hospitals in the United States, the mean in-hospital EBF rate for infants in the general population was 51.4% [6]. Recently, we reported EBF rates in women with mild CHTN (47%) and with severe CHTN (50%) [25], with preeclampsia (39%) and with severe preeclampsia (37%) [26], with preeclampsia superimposed on pregestational diabetes (18%) [27], with CHTN superimposed on pregestational diabetes (19%) [28], and with pregestational diabetes with prior BF experience (33%) and without prior BF experience (11%) [9]. In line with the above, the low EBF rates associated with excessive GWG for Type 1 and Type 2 (27%), prior BF experience (33%), Grade 1 obesity (28%), Grade 2 (33%) and Grade 3 (22%) reported here are similar to those of women with pregestational diabetes and superimposed comorbidities described above [9,2528]. Based on those experiences we are inclined to speculate that the high incidence of hypoglycemia and NICU admission unique to pregestational diabetes could explain the further decrease on the rate of EBF. In addition, women who BF exclusively by EBM without any direct BF is also of concern because pumping without feeding at the breast is associated with shorter BF duration [29].

Delayed lactogenesis II may be a contributing factor to the low EBF among women with diabetes, obesity and excessive GWG reported here [11,30,31]. Obesity is also likely to be associated with comorbidities such as preeclampsia, CHTN and preexisting diabetes that increase the risk for cesarean delivery, indicated prematurity and neonatal hypoglycemia, factors known to negatively influence BF rates [26,32,33]. GWG above the target recommendations has also been associated with the development of childhood obesity [34]. Given that EBF has been shown to lower the risk for childhood obesity by up to 25% [34], improvement in BF rates in this population is a desirable objective.

Our data also showed that women with excessive GWG and no prior BF experience had the lowest EBF at discharge. A positive BF experience improves attitude, confidence, self-efficacy, motivation and intention to BF [9,34]. Negative BF experiences are related to maternal or neonatal morbidities, to difficulties inherent to lactation such as perception of low milk supply, suck or latch problems, mastitis or nipple fissures [9,35,36]. A detailed BF history can provide insight into obstacles that led to unsuccessful BF and may help to define appropriate preventive or corrective strategies for subsequent pregnancies [9].

In the present study we observed BF initiation rates for women with Type 1 (76%), with Type 2 (69%), with Grade 1 obesity (76%), Grade 2 (73%) and Grade 3 (68%). Considering the above, the BF initiation rates reported here, albeit lower, are comparable to the 83.2% reported recently for the general U.S. population [37]. Obstacles known to associate with low EBF and BF initiation affecting our study population included lack of prior BF experience, preeclampsia, CHTN, pregestational diabetes, obesity, complications of labor, cesarean delivery, premature birth, excessive GWG, neonatal hypoglycemia, admission to NICU, late BF, formula supplementation, delayed lactogenesis II and maternal-infant separation [7,2530,38]. The low current smoking rate observed in all subgroups of women studied here may be due to the success of prenatal smoking cessation programs [39].

The high rate of partial BF at the time of discharge may characterize two groups of women. Those who intended only to BF and were unable to EBF at discharge may be a group of women who with support and encouragement could reinitiate and maintain EBF. The other group was composed of women who prenatally intended partial BF and accomplished their goal. Unfortunately, our data also showed that one half of women who intended partial BF failed and were discharged feeding formula only, a circumstance unlikely to be reversed [38]. In line with previous reports, our data showed that public assistance was more common among women who intended partial BF at discharge and for those women with type 2 diabetes [40,41]. It is evident that each of these groups might require different educational strategies if their lactation goals are to be achieved.

The reported prevalence of excessive GWG ranged from 36 to 73% for women with obesity [1516,4245], from 36 to 54% for women with gestational diabetes [17,45,46] and from 41 to 64% for women with obesity and pregestational diabetes [46,47]. The higher prevalence of excessive GWG (76%) reported here for the three obesity grades may be the result of the combination of diabetes mellitus and obesity that characterized our study population.

In 2012, Bartok et al, using the 2009 guidelines, noted that neither BMI nor GWG was associated with BF outcomes [14]. Subsequently, Winkvist et al reported that Norwegian women with obesity who experience excessive GWG had a higher inability to sustain full or any BF [15]. More recently, it was reported that among Brazilian women with obesity, excessive GWG was not associated with any EBF or BF [16]. However, Haile et al reported that among women with gestational diabetes and excessive GWG, the odds of EBF during the neonatal period and at three months postpartum were lower compared to women without diabetes [17]. In our special population of women with multiple co-morbidities, excessive GWG may have been a contributor, but it was not an independent predictor of low EBF or BF initiation.

Our regression analysis showed that neonatal hypoglycemia was a predictor of EBF failure among women with Type 1 and Type 2 and obesity. Indeed, hypoglycemia, lack of early BF and admission to the NICU are well known interrelated obstacles to EBF and BF initiation, especially among infants born to women with gestational and pregestational diabetes [8,26,27,38]. Early BF or early FF may facilitate glycemic stability and prevent or correct hypoglycemia avoiding the need for dextrose gel, IV treatment or formula supplementation [8]. However, our data showed that approximately one third of the infants with hypoglycemia required admission to the NICU with the unavoidable mother-infant separation that is another strong physical and psychological barrier to EBF.

It is known that racial discrepancies are accompanied by low rates of any BF and EBF in African Americans and Hispanics as compared to non-Hispanic whites [48]. In line with the above, our data on women with Type 2 diabetes showed that BF initiation among Hispanics and African Americans was lower than among those of non-Hispanic white women. However, rates of excessive GWG were comparable across ethnic groups.

A limitation of this investigation is that the calculation of GWG was based on pregestational weight measured during the first prenatal visit or by maternal recall at the time of delivery. Another limitation is the lack of follow-up information regarding infant feeding choices after discharge from the hospital. The strength of this study rests on the use, for the first time, of GWG guidelines applicable to women with various degrees of obesity. Finally, the data of the obstetrical and neonatal population was obtained directly from medical records, and not via post-delivery maternal questionnaires.

In conclusion, the prevalence of excessive GWG is high among women with diabetes, but similar across all grades of obesity. Compared to healthier maternal populations, women with Type 1 and Type 2 diabetes, obesity and excessive GWG are likely to have very low rates of EBF and similar BF initiation rates. Women who intended to BF only are more likely to EBF while those who intended partial BF are at higher risk of BF initiation failure. Diverse maternal and neonatal comorbidities create obstacles to lactation, however, excessive GWG is not associated with either EBF success or failure among women with pregestational diabetes and obesity.

References

  1. 1. Gunderson EP, Hurston SR, Ning X, Lo JC, Crites Y, Walton D, et al. Lactation and progression to type 2 diabetes mellitus: a prospective cohort study. Ann Intern Med 2015;163:889–98.
  2. 2. Stuebe A. Associations among lactation, maternal carbohydrate metabolism and cardiovascular health. Clin Obstet Gynecol 2015;58:827–39. pmid:26457850
  3. 3. Binns C, Lee M, Low WY. The long-term public health benefits of breastfeeding. Asia Pac J Public Health 2016;28:7–14. pmid:26792873
  4. 4. Nguyen B, Jin K, Ding D. Breastfeeding and maternal cardiovascular risk factors and outcomes: A systematic review. PLoS ONE 2017;12(11): e0187923 pmid:29186142
  5. 5. JCAHO Specifications manual for national quality measures (v2015B). Accessed 1/19/2021 from https://manual.jointcommission.org.
  6. 6. Barrera CM, Beauregard JL, Nelson JM, Perrine CG. Association of maternity care practices and policies with in-hospital exclusive breastfeeding in the United States. Breastfeed Med 2019;14:243–248. pmid:30807205
  7. 7. Cordero L, Thung S, Landon MB, Nankervis CA. Breastfeeding initiation failure in women with pregestational diabetes mellitus. Clin Pediatr 2014;53:18–25.
  8. 8. Cordero L, Ramesh S, Hillier K, Giannone PJ, Nankervis CA. Early feeding and neonatal hypoglycemia in infants of diabetic mothers. SAGE Open Med 2018;1: 2050312113516613. pmid:26770697
  9. 9. Cordero L, Stenger MR, Landon MB, Nankervis CA. Exclusive breastfeeding among women with type 1 and type 2 diabetes mellitus. BMC Pregnancy Childbirth 2022;22:69, pmid:35086505
  10. 10. Oza-Frank R, Gunderson EP. In-hospital breastfeeding experiences among women with gestational diabetes. Breastfeed Med 2017;12:261–67. pmid:28632447
  11. 11. Ramji N, Challa S, Murphy PA, Quinlan J, Crane JMG. A comparison of breastfeeding rates by obesity class. J Matern Fetal Neonatal Med 2018;31:3021–3026. pmid:28760080
  12. 12. Kominiarek MA, Saade G, Mele L, Bailit J, Reddy UM, Wapner RJ, et al. Association between gestational weight gain and perinatal outcomes. Obstet Gynecol 2018;132:875–81. pmid:30204701
  13. 13. Champion ML, Harper LM. Gestational weight gain: Update on outcomes and interventions. Current Diabetes Reports 2020;20:1–10.
  14. 14. Bartok CJ, Schaefer EW, Beiler JS, Paul IM. Role of body mass index and gestational weight gain in breastfeeding outcomes. Breastfeed Med 2012;7:448–56. pmid:23215909
  15. 15. Winkvist A, Brantsaeter AL, Brandhagen M, Haugen M, Meltzer HM, Lissner L. Maternal prepregnant body mass index and gestational weight gain are associated with initiation and duration of breastfeeding among Norwegian mothers. J Nutr 2015;145:1263–70. pmid:25904732
  16. 16. Castillo H, Santos IS, Matijasevich . Maternal pre-pregnancy BMI, gestational weight gain and breastfeeding. Eur J Clin Nutr 2016;70:431–36. pmid:26813940
  17. 17. Haile ZT, Chertok IRA, Chavan BB, Teweldeberhan AK, Stocum R. Combined influence of gestational diabetes and gestational weight gain on exclusive breastfeeding. Breastfeed Med 2019;14:538–550. pmid:31298552
  18. 18. LifeCycle Project-Maternal Obesity and Childhood Outcomes Study Group. Association of gestational weight gain with adverse maternal and infant outcomes. JAMA 2019;321:1702–1715, pmid:31063572
  19. 19. ACOG Practice Bulletin #201. Pregestational diabetes mellitus. Obstet Gynecol 2018;132:e228.
  20. 20. ACOG Practice Bulletin #203. Chronic hypertension in pregnancy. Obstet Gynecol 2019;133:e26.
  21. 21. ACOG Practice Bulletin #202. Summary: Gestational hypertension and preeclampsia. Obstet Gynecol 2019;133:211–214.
  22. 22. Greiner KS, Speranza RJ, Rincón M, Beeraka SS, Burwick RM. Association between insurance type and pregnancy outcomes in women diagnosed with hypertensive disorders of pregnancy. J Matern Fetal Neonatal Med 2020;33:1427–1433. pmid:30182768
  23. 23. Olsen IE, Groveman SA, Lawson L, Clark RH, Zemel BS. New Intrauterine growth curves based on United States data. Pediatrics 2010;12:e214–e224. pmid:20100760
  24. 24. Boies EG, Vaucher YE. ABM Clinical Protocol #10: Breastfeeding the late preterm (34–36 6/7 weeks of gestation) and early term infants (37–38 6/7 weeks of gestation), second revision 2016. Breastfeed Med 2016;11:494–500. pmid:27830934
  25. 25. Cordero L, Stenger MR, Landon MB, Nankervis CA. Breastfeeding initiation among women with chronic hypertension. Int J Womens Health Wellness 2021;7:118.
  26. 26. Cordero L, Stenger MR, Landon MB, Nankervis CA. Breastfeeding initiation among women with preeclampsia with and without severe features. J Neonatal Perinatal Med 2020 Dec 14. online ahead of print. pmid:33337389
  27. 27. Cordero L, Stenger MR, Landon MB, Nankervis CA. Breastfeeding initiation among women with preeclampsia with severe features superimposed on diabetes mellitus. Int J Women’s Health Wellness 2021,6:115.
  28. 28. Cordero L, Stenger MR, Landon MB, Nankervis CA. Breastfeeding initiation among women with chronic hypertension superimposed on pregestational diabetes mellitus. J Neonatal Perinatal Med 2021; online ahead of print. pmid:34397424
  29. 29. Keim SA, Boone KM, Oza-Frank R, Geraghty SR. Pumping milk without ever feeding at the breast in the Moms2Moms study. Breastfeed Med 2017;12:422–429. pmid:28727931
  30. 30. Preusting I, Brumley J, Odibo L, Spatz DL, Louis JM. Obesity as a predictor of delayed lactogenesis II. J Hum Lact 2017;33:684–91. pmid:28863267
  31. 31. Nomura K, Minamizono S, Nagashima K, One M, Kitano N. Maternal body mass index and breastfeeding non-initiation and cessation: A quantitative review of the literature. Nutrients 2020;12:2684. pmid:32887461
  32. 32. Hobbs AJ, Mannion CA, McDonald SW, Brockway M, Tough SC. The impact of caesarean section on breastfeeding initiation, duration and difficulties in the first four months postpartum. BMC Pregnancy Childbirth 2016;16:90. pmid:27118118
  33. 33. Nehring I, Lehmann S, von Kries R. Gestational weight gain in accordance to the IOM/NRC criteria and the risk for childhood overweight: a meta-analysis. Pediatr Obes 2013;8:218–24. pmid:23172639
  34. 34. Rito AI, Buoncristiano M, Spinelli A, Salanave B, Kunešová M, Hejgaard T, et.al. Association between characteristics at birth, breastfeeding and obesity in 22 countries: The WHO European childhood obesity surveillance initiative–COSI 2015/2017. Obes Facts 2019;12:226–243. pmid:31030194
  35. 35. Huang Y, Ouyang YQ, Redding SR. Previous breastfeeding experience and its influence on breastfeeding outcomes in subsequent births: A systematic review. Women Birth 2019;32:303–9. pmid:30274877
  36. 36. Colombo L, Crippa BL, Consonni D, Bettinelli ME, Agosti V, Mangino G, et al. Breastfeeding determinants in healthy term newborns. Nutrients 2018;10:48. pmid:29304013
  37. 37. Centers for Disease Control and Prevention (2018). Breastfeeding report card: United States 2018, Atlanta, GA: Centers for disease control and prevention. Accessed 1/19/2021 from https://www.cdc.gov/breastfeeding/pdf/2018breastfeedingreportcard.pdf.
  38. 38. Cordero L, Oza-Frank R, Moore-Clingenpeel M, Landon MB, Nankervis CA. Failure to initiate breastfeeding among high risk obstetrical patients who intended to breastfeed. J Neonatal Perinatal Med 2016;9:401–409. pmid:28009330
  39. 39. Scheffers-van Schayck T, Tuithof M, Otten R, Engels R, Kleinjan M. Smoking behavior of women before, during, and after pregnancy: Indicators of smoking, quitting, and relapse. Eur Addict Res 2019;25:132–144. pmid:30917383
  40. 40. Hundalani SG, Irigoyen M, Braitman LE, Matam R, Mandakovic-Falconi S. Breastfeeding among inner-city women: From intention before delivery to breastfeeding at hospital discharge. Breastfeed Med 2013;8:68–72. pmid:22849375
  41. 41. Breathett K, Filley J, Pandey M, Rai N, Peterson PN. Trends in early prenatal care among women with pre-existing diabetes: Have income disparities changes? J Womens Health (Larchmt) 2018;27:93–98/jwh.2016.6031.
  42. 42. Bodnar LM, Siega-Riz AM, Simhan HN, Himes KP, Abrams B. Severe obesity, gestational weight gain, and adverse birth outcomes. Am J Clin Nutr 2010;91:1642–8. pmid:20357043
  43. 43. Johnson J, Clifton RG, Roberts JM, Myatt L, Hauth JC, Spong CY, et al. Pregnancy outcomes with weight gain above or below the 209 Institute of Medicine guidelines. Obstet Gynecol 2013;121:969–75. pmid:23635732
  44. 44. Ukah UV, Bayrampour H, Sabr Y, Razaz N, Chan WS, Lim KI, et al. Association between gestational weight gain and severe adverse birth outcomes in Washington State, US: A population-based retrospective cohort study, 2004–2013. PLoS Med 2019;16(12): e1003009. pmid:31887140
  45. 45. Amyx M, Zeitlin J, Hermann M, Castetbon K, Blondel B, Le Ray C. Maternal characteristics associated with gestational weight gain in France: a population-based, nationally representative study. BMJ Open 2021;11:e049497. pmid:34215613
  46. 46. Egan AM, Dennedy MC, Al-Ramli W, Heerey A, Avalos G, Dunne F. Atlantic-Dip: Excessive gestational weight gain and pregnancy outcomes in women with gestational or pregestational diabetes mellitus. J Clin Endocrinol Metab 2014;99:212–219. pmid:24187402
  47. 47. Yee LM, Cheng YW, Inturrisi M, Caughley AB. Effect of gestational weight gain on perinatal outcomes in women with type 2 diabetes mellitus using the 2009 Institute of Medicine guidelines. Am J Obstet Gynecol 2011;205:257.e1–257.e6. pmid:22071055
  48. 48. Beauregard JL, Hamner HC, Chen J, Avila-Rodriguez W, Elam-Evans LD, Perrine CG. Racial disparities in breastfeeding initiation and duration among U.S. infants born in 2015. MMWR Morb Mortal Wkly Rep 2019;68:745–48. pmid:31465319